Status:
COMPLETED
Observational Prospectif Monocentric Registry of Patients Suffering From VIE
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Venous Thromboembolic Disease
Eligibility:
All Genders
Brief Summary
Patients with an episode of VTE (DVT and / or PE) have a mortality rate of 16-21% at 1 year after diagnosis. Morbidity associated with VTE is marked by the risk of recurrence, estimated at 30% and est...
Eligibility Criteria
Inclusion
- diagnosis of venous thromboembolism established by a validated test (venous Doppler ultrasound of the lower limbs, pulmonary angiography, lung scan ventilation / perfusion),
- diagnosis of venous thromboembolism made within 15 days,
- the previous inclusion in the register (outpatient or inpatient)
Exclusion
- person doesn't wish to participate in this study
Key Trial Info
Start Date :
October 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2017
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT02188056
Start Date
October 1 2014
End Date
August 31 2017
Last Update
September 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service Des Maladies Vasculaires - Hta - Nhc
Strasbourg, France, 67091